In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we? (2025)
Salata, Giovanna Cassone 
; Hirokawa, Camila Megumi ; Melo, Giovanna Barros de ; Malagó, Isabella Draszesski ; Nunes, Jessica Ribeiro ; Passos, Julia Sapienza ; Daré, Regina Gomes ; Lopes, Luciana Biagini
Source: Cancer Nanotechnology. Unidade: ICB
Subjects: FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NANOPARTÍCULAS, ORGANELAS CELULARES, NANOCIÊNCIA, QUIMIOTERÁPICOS, CITOESQUELETO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALATA, Giovanna Cassone et al. In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?. Cancer Nanotechnology, v. 16, p. 66 , 2025Tradução . . Disponível em: https://doi.org/10.1186/s12645-025-00321-6. Acesso em: 29 jun. 2025.APA
Salata, G. C., Hirokawa, C. M., Melo, G. B. de, Malagó, I. D., Nunes, J. R., Passos, J. S., et al. (2025). In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we? Cancer Nanotechnology, 16, 66 . doi:10.1186/s12645-025-00321-6NLM
Salata GC, Hirokawa CM, Melo GB de, Malagó ID, Nunes JR, Passos JS, Daré RG, Lopes LB. In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we? [Internet]. Cancer Nanotechnology. 2025 ; 16 66 .[citado 2025 jun. 29 ] Available from: https://doi.org/10.1186/s12645-025-00321-6Vancouver
Salata GC, Hirokawa CM, Melo GB de, Malagó ID, Nunes JR, Passos JS, Daré RG, Lopes LB. In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we? [Internet]. Cancer Nanotechnology. 2025 ; 16 66 .[citado 2025 jun. 29 ] Available from: https://doi.org/10.1186/s12645-025-00321-6
